Literature DB >> 33819206

Growth Faltering and Developmental Delay in HIV-Exposed Uninfected Ugandan Infants: A Prospective Cohort Study.

Reshma Sirajee1, Andrea L Conroy2, Sophie Namasopo3, Robert O Opoka4, Stephanie Lavoie5, Sarah Forgie1, Bukola O Salami6,7, Michael T Hawkes1,6,8,9,10.   

Abstract

BACKGROUND: HIV-exposed but uninfected (HEU) infants are at increased risk of impaired early linear growth and cognitive development. We examined associations between prenatal and postnatal growth and subsequent neurodevelopment in Ugandan HEU infants, hypothesizing that early insults may explain alterations in both somatic growth and brain development.
METHODS: We prospectively followed a cohort of HEU infants from birth to 18 months of age, and measured length/height, weight, head, and arm circumference longitudinally. The Malawi Development Assessment Tool (MDAT, 12 and 18 months) and the Color Object Association Test (18 months) were used for developmental assessments.
RESULTS: Among 170 HEU infants, the prevalence of low-birth weight and failure to thrive was 7.6% and 37%, respectively. HEU infants had MDAT scores that were similar to the reference population. The mean (SD) score on the Color Object Association Test was 5.5 (3.1) compared with 6.9 (5.3) in developmentally normal children. Developmental ability at age 18 months showed strong cross-sectional correlation with weight-for-age (ρ = 0.36, P < 0.0001), length/height-for-age (ρ = 0.41, P < 0.0001), head circumference-for-age (ρ = 0.26, P = 0.0011), and mid-upper arm circumference-for-age (ρ = 0.34, P = 0.0014). There was a statistically significant correlation between birth weight and MDAT z-score at 18 months (ρ = 0.20, P = 0.010). Failure to thrive was associated with lower MDAT z-score [median -0.13 (IQR -0.75 to +0.14) versus +0.14 (IQR -0.44 to +0.63), P = 0.042].
CONCLUSION: Growth faltering in HEU infants was associated with lower attainment of developmental milestones at age 18 months. Our findings point to a simple screening method for identifying HEU infants at risk for developmental intervention.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33819206     DOI: 10.1097/QAI.0000000000002626

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

1.  Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.

Authors:  Dorothy C Nyemba; Emma Kalk; Michael J Vinikoor; Hlengiwe P Madlala; Mwangelwa Mubiana-Mbewe; Maureen Mzumara; Carolyn Bolton Moore; Amy L Slogrove; Andrew Boulle; Mary-Ann Davies; Landon Myer; Kathleen Powis
Journal:  BMC Public Health       Date:  2022-01-10       Impact factor: 4.135

2.  Cognitive Outcomes at 18 Months: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.

Authors:  Tarina Parpia; Erling Svensen; Sarah Elwood; Anne Wanjuhi; Ladislaus Blacy; Eliwaza Bayo; Eric Houpt; Elizabeth Rogawski McQuade; Mark DeBoer; James Platts-Mills; Estomih Mduma; Rebecca Scharf
Journal:  Am J Trop Med Hyg       Date:  2021-12-06       Impact factor: 2.345

3.  The association of breastfeeding with cognitive development and educational achievement in sub-Saharan Africa: A systematic review.

Authors:  Shamsudeen Mohammed; Laura L Oakley; Milly Marston; Judith R Glynn; Clara Calvert
Journal:  J Glob Health       Date:  2022-09-03       Impact factor: 7.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.